ESCAPE: Molecular mechanisms of disease progression and renoprotective pharmacotherapy in children with chronic renal failure

• Unité de recherche: PCRD EU
• Numéro de projet: 02.0277
• Titre du projet anglais: ESCAPE: Molecular mechanisms of disease progression and renoprotective pharmacotherapy in children with chronic renal failure

Mots-clé (Italien)

Life Sciences; Medicine; Health; Scientific Research

Autre Numéro de projet (Anglais)

EU project number: QLG1-CT-2002-00908

Programme de recherche (Anglais)

EU-programme: 5. Frame Research Programme - 1.1.8 Generic R&D activities

Description succincte (Anglais)

See abstract

Autres indications (Anglais)

Full name of research-institution/enterprise:
Kinderspital Zürich Eleonorenstiftung / Universitäts-Kinderklinik

Résumé des résultats (Abstract) (Anglais)

ACE inhibitors are renoprotective in adults with chronic renal failure (CRF), but of unproven usefulness in children. In a randomized trial in 350 CRF children we will address if ACE inhibition is efficacious in slowing CRF progression in acquired and congenital nephropathies, if progression can be additionally influenced by intensified antihypertensive treatment achieving low-normal blood pressure, and which factors determine CRF progression and/or its susceptibility to ACE inhibition. Potential effects of renin-angiotensin system and PAI-l gene polymorphisms, mutations in genes defining glomerular structure or causing renal hypo/dysplasia, renal endothelnr-l turnover, plasma homocysteine and apolipoprotein phenotypes will be assessed. The cardiovascular consequences of childhood-onset CRF and renoprotective pharmacotherapy will be addressed bycarotid ultrasound, echocardiography and 24-hour blood presssure moritoring.

Références bases de données (Anglais)

Swiss Database: Euro-DB of the
State Secretariat for Education and Research
Hallwylstrasse 4
CH-3003 Berne, Switzerland
Tel. [phone]
Swiss Project-Number: 02.0277